AMGEN INC — Director's Dealing 2021

Feb 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2021-02-08

Reporting Person: Williams R Sanders (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-08	Common Stock	S	250	$237.99	Disposed	4659	Direct

Footnotes

F1: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.